Apolipoprotein A-IV stimulates duodenal vagal afferent activity to inhibit gastric motility via a CCK1 pathway
Authors:
- N. DarcelNDN. Darcel
- A. J. RechsARA. J. Rechs
- T. J. KalogerisTKT. J. Kalogeris
- P. TsoPTP. Tso
- H. E. RaybouldHRH. E. Raybould
- 1 August 2004
- journal article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 287 (2) , R354-R359
Abstract
Apolipoprotein A-IV (apo A-IV), a peptide expressed by enterocytes in the mammalian small intestine and released in response to long-chain triglyceride absorption, may be involved in the regulation of gastric acid secretion and gastric motility. The specific aim of the present study was to determine the pathway involved in mediating inhibition of gastric motility produced by apo A-IV. Gastric motility was measured manometrically in response to injections of either recombinant purified apo A-IV (200 μg) or apo A-I, the structurally similar intestinal apolipoprotein not regulated by triglyceride absorption, close to the upper gastrointestinal tract in urethane-anesthetized rats. Injection of apo A-IV significantly inhibited gastric motility compared with apo A-I or vehicle injections. The response to exogenous apo A-IV injections was significantly reduced by 77 and 55%, respectively, in rats treated with the CCK1 receptor blocker devazepide or after functional vagal deafferentation by perineural capsaicin treatment. In electrophysiological experiments, isolated proximal duodenal vagal afferent fibers were recorded in vitro in response to close-arterial injection of vehicle, apo A-IV (200 μg), or CCK (10 pmol). Apo A-IV stimulated the discharge of duodenal vagal afferent fibers, significantly increasing the discharge in 4/7 CCK-responsive units, and the response was abolished by CCK1 receptor blockade with devazepide. These data suggest that apo A-IV released from the intestinal mucosa during lipid absorption stimulates the release of endogenous CCK that activates CCK1 receptors on vagal afferent nerve terminals initiating feedback inhibition of gastric motility.Keywords
This publication has 21 references indexed in Scilit:
- Chylomicron components activate duodenal vagal afferents via a cholecystokinin A receptor‐mediated pathway to inhibit gastric motor function in the ratThe Journal of Physiology, 2003
- Expression of biologically active rat apolipoprotein AIV in Escherichia coli.Physiology & Behavior, 2003
- Chylomicron components mediate intestinal lipid-induced inhibition of gastric motor functionAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2002
- Vagal afferent responses to fatty acids of different chain length in the ratAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2001
- Effect of leptin on intestinal apolipoprotein AIV in response to lipid feedingAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2001
- Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats.Journal of Clinical Investigation, 1993
- Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiationAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1992
- Fat feeding increases size, but not number, of chylomicrons produced by small intestineAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 1990
- Comparison of effects of ingested mediumand long-chain triglyceride on gallbladder volume and release of cholecystokinin and other gut peptidesDigestive Diseases and Sciences, 1987
- A relation between the chain length of fatty acids and the slowing of gastric emptyingThe Journal of Physiology, 1968